Sangamo Therapeutics: Navigating the Biotech Rollercoaster with Recent Milestones and Market Volatility
Sangamo Therapeutics, a biotech company, has experienced a volatile stock ride, but recent advancements bring hope for breakthroughs in genetic therapy, making it a high-risk, high-reward investment opportunity.
2 minutes to read